Ana Fernandez-Montes

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
649 Background: In ASCO2004, Y. Fernandez et al. showed their experience in gemcitabine/capecitabine use in patients with metastatic advanced colorectal cancer (ACRC), with previous progression or contraindicated standar treatment, with encouraging results. This study was design to evaluate the efficacy and safety of this combination in these patients, in(More)
  • 1